Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.
Drummond M, Evans B, LeLorier J, Karakiewicz P, Martin D, Tugwell P, MacLeod S. Drummond M, et al. Can J Clin Pharmacol. 2009 Summer;16(2):e273-81; discussion e282-4. Epub 2009 May 13. Can J Clin Pharmacol. 2009. PMID: 19439771
Drug reimbursement policies in Canada--need for improved access to critical therapies.
LeLorier J, Bell A, Bougher DJ, Cox JL, Turpie AG. LeLorier J, et al. Ann Pharmacother. 2008 Jun;42(6):869-73. doi: 10.1345/aph.1K373. Epub 2008 May 13. Ann Pharmacother. 2008. PMID: 18477735
Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.
Mitchell D, Guertin JR, Iliza AC, Fanton-Aita F, LeLorier J. Mitchell D, et al. Mol Diagn Ther. 2017 Feb;21(1):95-105. doi: 10.1007/s40291-016-0238-8. Mol Diagn Ther. 2017. PMID: 27798813 Free PMC article.
A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.
Mitchell D, Guertin JR, Dubois A, Dubé MP, Tardif JC, Iliza AC, Fanton-Aita F, Matteau A, LeLorier J. Mitchell D, et al. Among authors: lelorier j. Mol Diagn Ther. 2018 Apr;22(2):241-254. doi: 10.1007/s40291-018-0323-2. Mol Diagn Ther. 2018. PMID: 29651791
Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies.
Poulin F, Khairy P, Roy D, Levesque S, Talajic M, Guertin JR, Lelorier J; Atrial Fibrillation and Congestive Heart Failure Trial Investigators. Poulin F, et al. Can J Cardiol. 2013 Oct;29(10):1256-62. doi: 10.1016/j.cjca.2013.03.005. Epub 2013 Jun 7. Can J Cardiol. 2013. PMID: 23751149 Clinical Trial.
A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine.
Iliza AC, Matteau A, Guertin JR, Mitchell D, Fanton-Aita F, Dubois A, Dubé MP, Tardif JC, LeLorier J. Iliza AC, et al. Pharmacogenomics. 2016 Oct;17(15):1693-1706. doi: 10.2217/pgs-2016-0054. Epub 2016 Oct 10. Pharmacogenomics. 2016. PMID: 27719379
176 results
Jump to page
Feedback